As a critical step towards bringing new medicines and vaccines safely to market, clinical trials provide Canadians with access to new, potentially life-saving medications and therapies. They also increase the […]
Ottawa, May 6, 2021—The extraordinary development of the COVID-19 vaccines now being deployed globally is a testament to collaboration and innovation by governments, industry, and other stakeholders. Waiving TRIPS Intellectual […]
IMC issued the following statement in response to calls for the disclosure […]
IMC issued the following statement […]
IMC issued the following statement today in response to questions […]
Dr. Doron Sagman is Lilly Canada’s Vice President of R&D and Medical Affairs as well as Lilly’s Senior Medical Director. Doron is a physician with nearly 20 years of experience […]
The Health Research Foundation of IMC is pleased to […]
Dr. Alex Romanovschi is GSK Canada’s Country Medical Director. Alex is a physician with nearly 20 years of experience in the pharmaceutical industry spanning many therapeutic areas, including cardiovascular diseases, […]
IMC today announced the creation of a Research Chair in pandemic preparedness […]
Vatche is the President and Founder of Vantage BioTrials, a Canadian CRO specialized in clinical trial management services. He’s contributed his strong drug development knowledge to the pharma and clinical […]
Dion Neame is the Country Medical Lead for Sanofi Canada and Country Medical Head for Pasteur, the vaccine arm of Sanofi. He is also a pediatrician working in Pediatric Urgent […]
In response to the global outbreak of COVID-19 […]
IMC released the following statement […]
Canada’s involvement in a “global megatrial” to quickly identify treatments for COVID-19 […]
Members of Innovative Medicines Canada continue to support front line workers […]
WIW is an opportunity for the global community […]
IMC welcomes today’s announcement by the federal […]
Despite the bad news related to COVID-19, there are some glimmers of hope. Health experts are reporting signs that the infection curve in Canada may be starting to flatten, while […]
The Canadian innovative pharmaceutical industry […]
A global pandemic of unprecedented proportions demands […]
Members of IMC are continuing their efforts in the fight against COVID-19 […]
Ottawa, April 1, 2020—Members of Innovative Medicines Canada (IMC) are continuing their efforts in the fight against COVID-19 by donating 100,000 KN95 masks for front-line healthcare workers battling the virus. […]
Canada’s innovative pharmaceutical industry is coming together to achieve one shared goal: the eradication of COVID-19. We are committed to and focused on creating new tests for the virus, on […]
Ottawa, March 23, 2020—Innovative Medicines Canada (IMC) issued the following statement in response to the federal government’s announcement today of measures to aid in the rapid mobilization of large-scale efforts […]
As Canada responds to the global COVID-19 pandemic […]
IMC issued the following statement […]
